Denmark – AfricaNewsAnalysis

Merck to Present New Research Focused on Hard-to-Treat Cancers at ESMO 2016

28/09/2016 ANA 0

Merck, a leading science and technology company, today announced that new research from their marketed and pipeline compounds will be presented at this year’s European Society for Medical Oncology (ESMO; October 7–11, 2016, Copenhagen, Denmark) […]

Environment Minister seeks foreign support to quicken Ghana’s protection

28/04/2016 ANA 0

Ghana’s Minister of Environment, Science, Technology and Innovation, Mr. Mahama Ayariga has held bilateral talks with his counterparts from various countries and heads of some international organizations at the United Nations headquarters in New York […]

Stop ”peace forum” in occupied territory, writes Peter Kenworthy, Africa Contact

09/02/2015 ANA 0

Africa Contact urges Crabs Montana Forum to move its forum in March from Africa’s last colony, Moroccan occupied Western Sahara. Other organisations deploring the holding of the forum in an occupied territory include the African […]

Denmark questions Swazi King Mswati on human rights – By Peter Kenworthy

28/10/2014 ANA 0

Denmark has raised the questions of political freedom, human rights, and the trial of political activists Mario Masuku and Maxwell Dlamini with Swaziland’s government and absolute monarch King Mswati III, Danish Minister of Foreign Affairs […]

Exclusive Interview with Mario Masuku by Eric Singh, ANA Snr. Editor

09/11/2013 ANA 0

Denmark: A solidarity group based in Denmark, attached to the Social Democratic Party of Denmark, has motivated that Mario Masuku, President of PUDEMO (People’s United Democratic Movement) of Swaziland) be awarded the DEMOCRACY AWARD for […]

New data show Novartis’ Gilenya® reduced brain volume loss by one third and confirm brain volume loss link with disability in MS patients

07/10/2013 ANA 0

Novartis recently announced new data indicating that continued treatment with Gilenya® (fingolimod) led to a reduction in brain volume loss in patients with relapsing forms of multiple sclerosis (MS), and was associated with a higher […]

Data at ECTRIMS to confirm Novartis’ Gilenya® long-term efficacy on reducing brain volume loss and real-world relapse rates in MS

25/09/2013 ANA 0

New data showing the benefits of Gilenya® (fingolimod) on patient outcomes in multiple sclerosis (MS) will be presented at the 29th Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS) in […]